NGEN
NervGen Pharma Corp.
1.80$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.4% | 94.6% | 97.9% | 98.0% | 97.7% | 97.6% | 97.2% | 97.4% | 96.8% | 98.2% | 98.1% | 99.6% | |
| 90.4% | 88.1% | 95.3% | 95.2% | 93.5% | 88.6% | 91.4% | 92.6% | 86.9% | 95.1% | 79.7% | 96.2% | |
| 90.4% | 88.1% | 95.3% | 95.2% | 93.5% | 89.1% | 91.9% | 93.0% | 87.2% | 95.1% | 79.7% | 96.2% | |
| 0.1% | 1.9% | 0.0% | 0.4% | 0.5% | 2.1% | 2.1% | 0.6% | 2.6% | 0.3% | 0.5% | 0.2% | |
| 3.3% | 3.9% | 1.6% | 1.8% | 2.1% | 2.4% | 2.8% | 2.6% | 3.2% | 1.8% | 1.9% | 0.4% | |
| 68.8% | 115.2% | 40.8% | 55.2% | 59.1% | 86.8% | 91.2% | 105.4% | 122.5% | 85.0% | 73.3% | 80.8% | |
| 68.0% | 114.4% | 40.5% | 55.0% | 59.0% | 86.7% | 91.2% | 105.4% | 122.5% | 85.0% | 73.3% | 80.8% | |
| 0.6% | 0.7% | 0.3% | 0.3% | 0.4% | 0.5% | 0.5% | 0.3% | 0.3% | 0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | 20.1% | – | – | |
| 31.2% | -15.2% | 59.2% | 44.8% | 40.9% | 13.2% | 8.8% | -5.4% | -22.5% | 15.0% | 26.7% | 19.2% | |
| -425.1% | -590.5% | -253.3% | -316.7% | -416.5% | -524.3% | -669.9% | -680.8% | -916.5% | -632.3% | -714.8% | -197.0% | |
| 364.3% | 450.3% | 189.1% | 251.0% | 312.5% | 361.2% | 448.7% | 423.1% | 558.7% | 311.6% | 385.0% | 102.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.